4.5 Editorial Material

Setting Our Sights on Infectious Diseases

期刊

ACS INFECTIOUS DISEASES
卷 6, 期 1, 页码 3-13

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.9b00371

关键词

-

资金

  1. Wellcome Trust Centre Award [203134/Z/16/Z]
  2. Bill & Melinda Gates Foundation [OPP1199837]
  3. Medicines for Malaria Venture
  4. Novartis Institutes for Biomedical Research (NIBR)
  5. Drug for Neglected Diseases initiative
  6. Bill and Melinda Gates Foundation [OPP1199837] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

In May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据